MSH2 and mismatch repair cancer syndrome 1: An additional case with a malignant OAN in this series (case 2) had evidence of mismatch repair deficiency on immunohistochemistry (loss of MSH2 and MSH6 expression) but no pathogenic germline or somatic variant was identified.